Recommended Topical Steroid for Dermatitis on the Arm in Canada
For dermatitis involving the arm in Canada, a medium-potency topical corticosteroid such as triamcinolone acetonide 0.1% cream applied twice daily for 2-3 weeks is recommended. 1
Selection of Topical Corticosteroid
Potency Selection
- Medium-potency topical corticosteroids are appropriate for most cases of dermatitis on the arm
- Options available in Canada include:
- Triamcinolone acetonide 0.1% (medium potency)
- Betamethasone valerate 0.1% (medium-high potency) for more severe cases 2
Formulation Selection
- Cream formulations are preferred for weeping or moist dermatitis
- Ointment formulations are better for dry, scaly dermatitis 1
Application Guidelines
Frequency and Duration
- Apply as a thin film twice daily 3
- Initial treatment duration: 2-3 weeks 1
- For the arm, approximately 30-60g is typically needed for a 2-week treatment course 1
Application Technique
- Apply a thin layer to affected areas
- One fingertip unit (approximately 0.5g) covers an area equivalent to two adult palms 4
Monitoring and Follow-up
Treatment Response Assessment
- Evaluate response after 2 weeks of treatment
- If no improvement is seen after 2 weeks, consider:
- Reassessing diagnosis
- Increasing potency of steroid
- Dermatology referral 1
Managing Side Effects
- Monitor for common local adverse effects:
- Skin atrophy
- Striae
- Telangiectasia
- Folliculitis 4
- Forearms are at higher risk for developing adverse effects with chronic use 4
Treatment Escalation
For Inadequate Response
- If inadequate response to medium-potency steroid:
For Severe Cases
- For severe dermatitis (covering >30% BSA with significant symptoms):
- Consider systemic corticosteroids (prednisone 0.5-1 mg/kg/day)
- Obtain same-day dermatology consultation 4
Adjunctive Measures
Skin Care
- Regular use of moisturizers, especially after washing
- Use soap-free shower gels
- Avoid known triggers and irritants 1
Pruritus Management
- Oral antihistamines (cetirizine/loratadine 10 mg daily or hydroxyzine 10-25 mg QID) can help control itching 4
Important Caveats
- Avoid prolonged use (>4 weeks) of high-potency steroids due to increased risk of local adverse effects 4
- Gradual reduction in frequency after clinical improvement is recommended to prevent rebound 4
- For facial or intertriginous areas, lower potency steroids should be used (Class V/VI) 4
- If secondary infection is suspected, topical steroids should be discontinued and appropriate antimicrobial therapy initiated 3